BioSpace News Archive

Biotech Beach

Ligand Receives $47 Million from WuXi Biologics for Expansion of Worldwide OmniAb® Platform License Agreement

Updates 2018 Full Year and Second Quarter Financial Guidance

June 27, 2018
·
8 min read
Drug Development

Omeros Obtains Approval to Initiate Phase 1 Clinical Trial for its OMS527 Addiction Treatment

First Clinical Target for PDE7 Inhibitor to be Nicotine Addiction

June 27, 2018
·
4 min read
BioCapital

American Pharmacists Association Earns the 2018 Commuter Connections

The American Pharmacists Association (APhA), has received the Metropolitan Washington Council of Governments’ Commuter Connections 2018 Employer Recognition Award.

June 27, 2018
·
3 min read
Cellectis S.A. Reports Results from Annual General Meeting Held on June 26, 2018

Cellectis S.A. Annual General Meeting was held on Tuesday, June 26, 2018 in Paris, at its head office.

June 27, 2018
·
1 min read
Pharm Country

Novartis announces funding for patient advocacy initiatives to support and empower metastatic breast cancer community

STEP (Solutions to Empower Patients)™ Program helps nonprofit organizations deliver innovative solutions to patient communities

June 27, 2018
·
7 min read
Biotech Beach

Arrowhead Receives Positive EMA Opinion on Orphan Designation for ARO-AAT for Treatment of Congenital Alpha-1 Antitrypsin Deficiency

ARO-AAT was previously granted orphan drug designation by the United States Food and Drug Administration in February 2018.

June 27, 2018
·
3 min read
Pharm Country

NucleoBio Concludes Preliminary Tests For New Drug to Treat Aggressive Prostate Cancer

Prostreat outperforms commercially available medications in inhibiting the growth and spread of the most aggressive form of prostate cancer: metastatic castration-resistant prostate cancer.

June 27, 2018
·
3 min read
BioMidwest

ANI Pharmaceuticals Announces Launch of Cholestyramine for Oral Suspension USP

The current annual U.S. market for this product is approximately $22 million, according to Iqvia/IMS Health.

June 27, 2018
·
3 min read
Pharm Country

BIO Announces GreenTech Investor Sessions at the 2018 World Congress in July

The Biotechnology Innovation Organization (BIO) today announced that nine emerging companies will make formal presentations to investors during GreenTech Investor Sessions at the 2018 BIO World Congress on Industrial Biotechnology.

June 27, 2018
·
3 min read
Business

Berlin Cures strengthens Business Advisory Board with the appointments of Ulf Berg, Ph.D., and Dragan Grabulovski, Ph.D.

Internationally Renowned Industry Veterans Provide Strategic Developmental Experience for the Company’s Transition to a Global Commercial Entity

June 27, 2018
·
4 min read